Found: 108
Select item for more details and to access through your institution.
A Case of Thoracic Spondylosis Deformance in a Boxer Dog.
- Published in:
- Kocatepe Veterinary Journal / Kocatepe Veteriner Dergisi, 2023, v. 16, n. 1, p. 118, doi. 10.30607/kvj.1180612
- By:
- Publication type:
- Article
2121. Isavuconazole (ISAV) as Primary Anti-Fungal Prophylaxis (PAP) in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS): An Open-Label, Prospective Study.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S718, doi. 10.1093/ofid/ofz360.1801
- By:
- Publication type:
- Article
Comparative Experimental İnvestigation and Application of Five Classic Pre-Trained Deep Convolutional Neural Networks via Transfer Learning for Diagnosis of Breast Cancer.
- Published in:
- Advances in Science & Technology Research Journal, 2021, v. 15, n. 3, p. 1, doi. 10.12913/22998624/137964
- By:
- Publication type:
- Article
Current status and research directions in acute myeloid leukemia.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01143-2
- By:
- Publication type:
- Article
A Phase I study of Milademetan (DS3032b) in combination with low dose cytarabine with or without venetoclax in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00871-1
- By:
- Publication type:
- Article
Correction: Manufacturing and Characterization of Al–xMg–xMgO Composites Using Stir Casting Process.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Manufacturing and Characterization of Al–xMg–xMgO Composites Using Stir Casting Process.
- Published in:
- International Journal of Metalcasting, 2023, v. 17, n. 3, p. 2308, doi. 10.1007/s40962-022-00946-y
- By:
- Publication type:
- Article
Fault detection in photovoltaic arrays: a robust regularized machine learning approach.
- Published in:
- DYNA - Ingeniería e Industria, 2020, v. 95, n. 6, p. 622, doi. 10.6036/9856
- By:
- Publication type:
- Article
Adropin as a potential marker of enzyme-positive acute coronary syndrome.
- Published in:
- Cardiovascular Journal of Africa, 2017, v. 28, n. 1, p. 40, doi. 10.5830/CVJA-2016-055
- By:
- Publication type:
- Article
Combination therapy with novel agents for acute myeloid leukaemia: Insights into treatment of a heterogenous disease.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 1, p. 30, doi. 10.1111/bjh.19519
- By:
- Publication type:
- Article
Characteristics and outcomes of acute myeloid leukaemia patients with baseline CD7 expression.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 6, p. 2259, doi. 10.1111/bjh.19446
- By:
- Publication type:
- Article
Flow cytometric immunophenotypic alterations of persistent clonal haematopoiesis in remission bone marrows of patients with NPM1‐mutated acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 1054, doi. 10.1111/bjh.17347
- By:
- Publication type:
- Article
Exploring the landscape of somatic ASXL2 mutations in myeloid neoplasms: Frequency and clinical implications.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 7, p. 1434, doi. 10.1002/ajh.27333
- By:
- Publication type:
- Article
Targetable genetic abnormalities in patients with acute myeloblastic leukemia across age groups.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 4, p. 792, doi. 10.1002/ajh.27236
- By:
- Publication type:
- Article
Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation treated in the pre‐ and post‐ponatinib era.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1619, doi. 10.1002/ajh.27037
- By:
- Publication type:
- Article
Evolving trends and outcomes in older patients with acute myeloid leukemia including allogeneic stem cell transplantation.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 9, p. 1383, doi. 10.1002/ajh.26997
- By:
- Publication type:
- Article
Ultrasensitive NGS MRD assessment in Ph+ ALL: Prognostic impact and correlation with RT‐PCR for BCR::ABL1.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 8, p. 1196, doi. 10.1002/ajh.26949
- By:
- Publication type:
- Article
The outcomes of patients with chronic myeloid leukemia treated with third‐line BCR::ABL1 tyrosine kinase inhibitors.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 4, p. 658, doi. 10.1002/ajh.26852
- By:
- Publication type:
- Article
Implications of RAS mutational status in subsets of patients with newly diagnosed acute myeloid leukemia across therapy subtypes.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 12, p. 1599, doi. 10.1002/ajh.26731
- By:
- Publication type:
- Article
Differential prognostic impact of RUNX1 mutations according to frontline therapy in patients with acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 12, p. 1560, doi. 10.1002/ajh.26724
- By:
- Publication type:
- Article
Clinical outcomes and impact of therapeutic intervention in patients with acute myeloid leukemia who experience measurable residual disease (MRD) recurrence following MRD‐negative remission.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. E408, doi. 10.1002/ajh.26698
- By:
- Publication type:
- Article
Contemporary outcomes in IDH‐mutated acute myeloid leukemia: The impact of co‐occurring NPM1 mutations and venetoclax‐based treatment.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. 1443, doi. 10.1002/ajh.26694
- By:
- Publication type:
- Article
Low‐dose dasatinib 50 mg/day versus standard‐dose dasatinib 100 mg/day as frontline therapy in chronic myeloid leukemia in chronic phase: A propensity score analysis.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. 1413, doi. 10.1002/ajh.26689
- By:
- Publication type:
- Article
Venetoclax combined with FLAG‐IDA induction and consolidation in newly diagnosed acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 8, p. 1035, doi. 10.1002/ajh.26601
- By:
- Publication type:
- Article
Urgent cytoreduction for newly diagnosed acute myeloid leukemia patients allows acquisition of pretreatment genomic data and enrollment on investigational clinical trials.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 7, p. 885, doi. 10.1002/ajh.26572
- By:
- Publication type:
- Article
Treatment‐free remission in patients with chronic myeloid leukemia following the discontinuation of tyrosine kinase inhibitors.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 7, p. 856, doi. 10.1002/ajh.26550
- By:
- Publication type:
- Article
Dismal outcomes of patients with relapsed/refractory Philadelphia chromosome‐negative B‐cell acute lymphoblastic leukemia after failure of both inotuzumab ozogamicin and blinatumomab.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 6, p. E201, doi. 10.1002/ajh.26526
- By:
- Publication type:
- Article
Improved outcomes among newly diagnosed patients with FMS‐like tyrosine kinase 3 internal tandem duplication mutated acute myeloid leukemia treated with contemporary therapy: Revisiting the European LeukemiaNet adverse risk classification.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 329, doi. 10.1002/ajh.26451
- By:
- Publication type:
- Article
Gilteritinib clinical activity in relapsed/refractory FLT3 mutated acute myeloid leukemia previously treated with FLT3 inhibitors.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 322, doi. 10.1002/ajh.26447
- By:
- Publication type:
- Article
FLT3 inhibitor based induction and allogeneic stem cell transplant in complete remission 1 improve outcomes in patients with newly diagnosed Acute Myeloid Leukemia with very low FLT3 allelic burden.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 8, p. E275, doi. 10.1002/ajh.26202
- By:
- Publication type:
- Article
Decitabine and venetoclax for IDH1/2‐mutated acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 5, p. E154, doi. 10.1002/ajh.26122
- By:
- Publication type:
- Article
Venetoclax with decitabine vs intensive chemotherapy in acute myeloid leukemia: A propensity score matched analysis stratified by risk of treatment‐related mortality.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 3, p. 282, doi. 10.1002/ajh.26061
- By:
- Publication type:
- Article
Serum ghrelin and obestatin levels in patients with acne vulgaris: are they important for the severity?
- Published in:
- Advances in Dermatology & Allergology / Postępy Dermatologii i Alergologii, 2019, v. 36, n. 4, p. 412, doi. 10.5114/ada.2019.87445
- By:
- Publication type:
- Article
From DNA Sequencing to Clinical Trials: Finding New Targeted Drugs for Acute Myeloid Leukemia.
- Published in:
- Drugs, 2019, v. 79, n. 11, p. 1177, doi. 10.1007/s40265-019-01144-7
- By:
- Publication type:
- Article
Examining Biomarker Levels in Patients Diagnosed with Multiple Sclerosis.
- Published in:
- Medical Journal of Bakirkoy, 2023, v. 19, n. 3, p. 283, doi. 10.4274/BMJ.galenos.2023.2023.6-2
- By:
- Publication type:
- Article
Kent Olgusu ve Kent-Din İlişkisi Üzerine Sosyolojik Bir Değerlendirme.
- Published in:
- Journal of Analytic Divinity, 2022, v. 6, n. 2, p. 9, doi. 10.46595/jad.1118445
- By:
- Publication type:
- Article
Serum osteopontin and vitronectin levels in systemic sclerosis.
- Published in:
- Advances in Clinical & Experimental Medicine, 2017, v. 26, n. 8, p. 1231, doi. 10.17219/acem/68627
- By:
- Publication type:
- Article
Serum adropin level and ENHO gene expression in systemic sclerosis.
- Published in:
- Clinical Rheumatology, 2016, v. 35, n. 6, p. 1535, doi. 10.1007/s10067-016-3266-1
- By:
- Publication type:
- Article
The clinical potential of inotuzumab ozogamicin in relapsed and refractory acute lymphocytic leukemia.
- Published in:
- Therapeutic Advances in Hematology, 2015, v. 6, n. 5, p. 253, doi. 10.1177/2040620715596715
- By:
- Publication type:
- Article
Similar outcome of patients with chronic myeloid leukemia treated with imatinib in or out of clinical trials.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Importance of HbA1c and fructosamine as a marker of glycemic control and evaluation of some biochemical parameters during pregnancy / Gebelik döneminde HbA1c ve fruktozaminin glisemik kontrol belirteci olarak önemi ve bazı biyokimyasal parametrelerin değerlendirmesi
- Published in:
- Turkish Journal of Biochemistry / Turk Biyokimya Dergisi, 2015, v. 40, n. 6, p. 533, doi. 10.1515/tjb-2015-0045
- By:
- Publication type:
- Article
İKİLİ TARAMA TESTİ PARAMETRELERİNİN BÖLGESEL MEDYAN DEĞERLERİNİN BELİRLENMESİ.
- Published in:
- Nobel Medicus Journal, 2018, v. 14, n. 2, p. 49
- By:
- Publication type:
- Article
Kentlileşme ve Aidiyet Bağlamında Sosyolojik Bir Araştırma: Ankara Örneği.
- Published in:
- Igdir University Journal of Social Sciences / Iğdır Üniversitesi Sosyal Bilimler Dergisi, 2023, n. 32, p. 325, doi. 10.54600/igdirsosbilder.1197256
- By:
- Publication type:
- Article
Clinical Value of Measurable Residual Disease in Acute Lymphoblastic Leukemia.
- Published in:
- Blood & Lymphatic Cancer: Targets & Therapy, 2022, v. 12, p. 7, doi. 10.2147/BLCTT.S270134
- By:
- Publication type:
- Article
Outcome of Patients With Relapsed Acute Promyelocytic Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 6, p. 375, doi. 10.1016/j.clml.2024.01.015
- By:
- Publication type:
- Article
AML-310: Prognostic Value of CRh in Acute Myeloid Leukemia Treated with Venetoclax and Decitabine.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S303, doi. 10.1016/S2152-2650(21)01721-3
- By:
- Publication type:
- Article
AML-297: Ten-Day Decitabine with Venetoclax vs Intensive Chemotherapy in Relapsed or Refractory Acute Myeloid Leukemia: A Propensity Score-Matched Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S303, doi. 10.1016/S2152-2650(21)01720-1
- By:
- Publication type:
- Article
AML-291: Treatment Response and Outcome in DNMT3A-mutated Acute Myeloblastic Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S301, doi. 10.1016/S2152-2650(21)01717-1
- By:
- Publication type:
- Article
AML-204: Venetoclax Combined with FLAG-IDA Induction and Consolidation in Newly Diagnosed Acute Myeloid Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S291, doi. 10.1016/S2152-2650(21)01696-7
- By:
- Publication type:
- Article
Poster: AML-310: Prognostic Value of CRh in Acute Myeloid Leukemia Treated with Venetoclax and Decitabine.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S216, doi. 10.1016/S2152-2650(21)01363-X
- By:
- Publication type:
- Article